S100A9: A Potential Biomarker for the Progression of Non-Alcoholic Fatty Liver Disease and the Diagnosis of Non-Alcoholic Steatohepatitis
Xiaolin Liu(Hebei Medical University), Yimin Mao(Fudan University), Xiaoyu Chen(Shanghai Jiao Tong University), Jingyi Zhang(Chengdu University of Traditional Chinese Medicine), Yongfeng Wang(Soochow University), Minde Zeng(Renji Hospital), Yanyan Song(Guangzhou Women and Children Medical Center), Yanan Ming(Shanghai Jiao Tong University)
Cited by 31
Related Papers
Identification of antimicrobial peptides from the human gut microbiome using deep learning
|Nature Biotechnology|2022|470
Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats
|Experimental & Molecular Medicine|2019|337
An adenovirus-vectored COVID-19 vaccine confers protection from SARS-COV-2 challenge in rhesus macaques
|Nature Communications|2020|247
Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression
|Experimental & Molecular Medicine|2018|212